During 2024, the following Position Statements, Professional Practice Guidelines and Clinical Memorandum have progressed and been approved by Board: 

Position Statements updated:

• Position Statement 78: Engagement with the Pharmaceutical Industry
• Position Statement 97: E-cigarettes and Vaporisers
• Position Statement 45: Prevention and treatment of gambling-related harm

Position Statements created:

• Position Statement 114: Sexual safety- Prevention of sexual harm and protection of consumers/tangata whaiora in acute inpatient mental health services
• Position Statement 46: The provision of mental health services for asylum seekers and refugees

Professional Practice Guidelines updated:

• Professional Practice Guideline 16: Administration of rTMS

Ethical Guidelines updated:

• Ethical Guideline 12: Zero tolerance policy on proven sexual boundary violations

Clinical Memorandum updated:

• Clinical Memorandum: Therapeutic use of medicinal cannabis

During 2024, the following Position Statements have been rescinded: 

• Position Statement 52: Mental health needs of child asylum seekers and refugees
• Position Statement 70: Suicide Reporting in the Media

During 2024, the following Professional Practice Guidelines have been rescinded: 

• Professional Practice Guideline 12: Guidance for psychiatrists working in Australian immigration detention centres
• Professional Practice Guideline 14: National codes and standards relevant to psychiatry practice and mental health services in Australia and New Zealand 

During 2024, the following Position Statements have been extended. 

• Position Statement 32: Abolition of torture and other inhuman treatment (PS32) (extended until 2027)
• Position Statement 88: Direct-to-consumer advertisement of Pharmaceuticals (extended until 2025)

To find out more about the College’s policy work and how to contribute, please email policy@ranzcp.org.